Blog

A growing body of research now supports the potential use of mushrooms containing the chemical psilocybin for a range of cognitive, mental and behavior disorders. Several research projects at Pacific Neuroscience Institute at Providence Saint John’s Health Center are aimed at determining the safety and...

A gratitude study uses beautiful videos on a mobile-based app to enhance well-being and adds to the Visual Healing® studies at Pacific Neuroscience Institute.

This year, seven of Pacific Neuroscience Institute Medical Group’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be...

Nature-themed visual experience and psilocybin therapy used for treatment of alcohol use disorder SANTA MONICA, Calif., March 18, 2021— Pacific Neuroscience Institute (PNI) has launched its first psychedelic-assisted clinical trial and begun participant enrollment. The Visual Healing® study is a collaboration among PNI, award-winning filmmaker...

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

Ketamine is approved for use at high doses as an anesthetic in the operating room. Although not FDA-approved, lower dose “sub-anesthetic” ketamine injections are used “off-label” to treat depression, pain, and other mental health/substance use disorders.  In recent times, there have been many factors contributing...

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.